Cargando…
Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
BACKGROUND: The aim of the study was to identify biomarkers that can facilitate early diagnosis and treatment of fulminant myocarditis (FM) in order to reduce mortality. METHODS AND RESULTS: First, the expression profiles of circulating cytokines were determined in the plasma samples from 4 patients...
Autores principales: | Wang, Jin, He, Mengying, Li, Huihui, Chen, Yanghui, Nie, Xiang, Cai, Yuanyuan, Xie, Rong, Li, Lijuan, Chen, Peng, Sun, Yang, Li, Chenze, Yu, Ting, Zuo, Houjuan, Cui, Guanglin, Miao, Kun, Zhao, Chunxia, Jiang, Jiangang, Heidecker, Bettina, Barnett, Olga, Maisel, Alan, Chen, Chen, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075487/ https://www.ncbi.nlm.nih.gov/pubmed/35377184 http://dx.doi.org/10.1161/JAHA.121.024417 |
Ejemplares similares
-
Circulating miR-4763-3p Is a Novel Potential Biomarker Candidate for Human Adult Fulminant Myocarditis
por: Nie, Xiang, et al.
Publicado: (2020) -
Myocardial strain features by 2D-STE during the course of fulminant myocarditis: Correlation with characteristics by CMR and clinical implications
por: Zuo, Houjuan, et al.
Publicado: (2021) -
Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
por: Wang, Daowen, et al.
Publicado: (2018) -
Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
por: Zhuang, Yan, et al.
Publicado: (2022) -
Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis
por: Cui, Guanglin, et al.
Publicado: (2022)